Literature DB >> 25359173

A p-Median approach for predicting drug response in tumour cells.

Elisabetta Fersini, Enza Messina, Francesco Archetti.   

Abstract

BACKGROUND: The complexity of biological data related to the genetic origins of tumour cells, originates significant challenges to glean valuable knowledge that can be used to predict therapeutic responses. In order to discover a link between gene expression profiles and drug responses, a computational framework based on Consensus p-Median clustering is proposed. The main goal is to simultaneously predict (in silico) anticancer responses by extracting common patterns among tumour cell lines, selecting genes that could potentially explain the therapy outcome and finally learning a probabilistic model able to predict the therapeutic responses.
RESULTS: The experimental investigation performed on the NCI60 dataset highlights three main findings: (1) Consensus p-Median is able to create groups of cell lines that are highly correlated both in terms of gene expression and drug response; (2) from a biological point of view, the proposed approach enables the selection of genes that are strongly involved in several cancer processes; (3) the final prediction of drug responses, built upon Consensus p-Median and the selected genes, represents a promising step for predicting potential useful drugs.
CONCLUSION: The proposed learning framework represents a promising approach predicting drug response in tumour cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25359173      PMCID: PMC4222443          DOI: 10.1186/s12859-014-0353-7

Source DB:  PubMed          Journal:  BMC Bioinformatics        ISSN: 1471-2105            Impact factor:   3.169


  41 in total

1.  Retroviral delivery of connexin genes to human breast tumor cells inhibits in vivo tumor growth by a mechanism that is independent of significant gap junctional intercellular communication.

Authors:  Hong Qin; Qing Shao; Heather Curtis; Jacques Galipeau; Daniel J Belliveau; Taiqi Wang; Moulay A Alaoui-Jamali; Dale W Laird
Journal:  J Biol Chem       Date:  2002-05-31       Impact factor: 5.157

2.  Prosaposin down-modulation decreases metastatic prostate cancer cell adhesion, migration, and invasion.

Authors:  Siyi Hu; Nathalie Delorme; Zhenzhen Liu; Tao Liu; Cruz Velasco-Gonzalez; Jone Garai; Ashok Pullikuth; Shahriar Koochekpour
Journal:  Mol Cancer       Date:  2010-02-04       Impact factor: 27.401

3.  Collections of simultaneously altered genes as biomarkers of cancer cell drug response.

Authors:  David L Masica; Rachel Karchin
Journal:  Cancer Res       Date:  2013-01-21       Impact factor: 12.701

Review 4.  Anti- and pro-tumor functions of autophagy.

Authors:  Eugenia Morselli; Lorenzo Galluzzi; Oliver Kepp; José-Miguel Vicencio; Alfredo Criollo; Maria Chiara Maiuri; Guido Kroemer
Journal:  Biochim Biophys Acta       Date:  2009-01-21

5.  POLR2F, ATP6V0A1 and PRNP expression in colorectal cancer: new molecules with prognostic significance?

Authors:  Anna G Antonacopoulou; Petros D Grivas; Lambros Skarlas; Melpomeni Kalofonos; Chrisoula D Scopa; Haralabos P Kalofonos
Journal:  Anticancer Res       Date:  2008 Mar-Apr       Impact factor: 2.480

6.  Expressing connexin 43 in breast cancer cells reduces their metastasis to lungs.

Authors:  Zhongyong Li; Zhiyi Zhou; Danny R Welch; Henry J Donahue
Journal:  Clin Exp Metastasis       Date:  2008-10-07       Impact factor: 5.150

7.  Hepatocyte growth factor activation inhibitors (HAI-1 and HAI-2) regulate HGF-induced invasion of human breast cancer cells.

Authors:  Christian Parr; Wen G Jiang
Journal:  Int J Cancer       Date:  2006-09-01       Impact factor: 7.396

8.  Investigating the correspondence between transcriptomic and proteomic expression profiles using coupled cluster models.

Authors:  Simon Rogers; Mark Girolami; Walter Kolch; Katrina M Waters; Tao Liu; Brian Thrall; H Steven Wiley
Journal:  Bioinformatics       Date:  2008-10-30       Impact factor: 6.937

9.  Entrez Gene: gene-centered information at NCBI.

Authors:  Donna Maglott; Jim Ostell; Kim D Pruitt; Tatiana Tatusova
Journal:  Nucleic Acids Res       Date:  2005-01-01       Impact factor: 16.971

10.  The microRNA.org resource: targets and expression.

Authors:  Doron Betel; Manda Wilson; Aaron Gabow; Debora S Marks; Chris Sander
Journal:  Nucleic Acids Res       Date:  2007-12-23       Impact factor: 16.971

View more
  5 in total

1.  Comprehensive anticancer drug response prediction based on a simple cell line-drug complex network model.

Authors:  Dong Wei; Chuanying Liu; Xiaoqi Zheng; Yushuang Li
Journal:  BMC Bioinformatics       Date:  2019-01-22       Impact factor: 3.169

Review 2.  Drug repurposing-an emerging strategy in cancer therapeutics.

Authors:  Khadija Shahab Turabi; Ankita Deshmukh; Sayan Paul; Dayanand Swami; Shafina Siddiqui; Urwashi Kumar; Shreelekha Naikar; Shine Devarajan; Soumya Basu; Manash K Paul; Jyotirmoi Aich
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2022-06-13       Impact factor: 3.195

3.  Improving drug response prediction by integrating multiple data sources: matrix factorization, kernel and network-based approaches.

Authors:  Betül Güvenç Paltun; Hiroshi Mamitsuka; Samuel Kaski
Journal:  Brief Bioinform       Date:  2021-01-18       Impact factor: 11.622

4.  Anticancer Drug Response Prediction in Cell Lines Using Weighted Graph Regularized Matrix Factorization.

Authors:  Na-Na Guan; Yan Zhao; Chun-Chun Wang; Jian-Qiang Li; Xing Chen; Xue Piao
Journal:  Mol Ther Nucleic Acids       Date:  2019-06-04

Review 5.  Computational models for predicting drug responses in cancer research.

Authors:  Francisco Azuaje
Journal:  Brief Bioinform       Date:  2017-09-01       Impact factor: 11.622

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.